In the Boardroom - Rare diseases

Filter

Current filters:

Rare diseases

Popular Filters

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

Back to top